Trials / Suspended
SuspendedNCT01744275
HOPE-Epilepsy Trial
High Dose Omega 3 Fatty Acids Supplementation in Patients With Epilepsy : The HOPE-Epilepsy Trial
- Status
- Suspended
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 370 (estimated)
- Sponsor
- Hospital do Coracao · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This a multi-center study to examine whether supplementation with omega 3 fatty acids will reduce seizure frequency in patients with epilepsy .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega 3 fatty acids | |
| DIETARY_SUPPLEMENT | corn oil | Placebo |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-07-01
- Completion
- 2016-07-01
- First posted
- 2012-12-06
- Last updated
- 2014-02-27
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01744275. Inclusion in this directory is not an endorsement.